Form D · Venture Capital Fund

Decheng Capital Global Life Sciences Fund V, L.P.

Grand Cayman, E9 · CIK 0002015545

Offering snapshot reported Oct 3, 2025 · SEC filing

Reported sold: $452M
Investors reported: 42
Minimum accepted: $0
First sale: Jun 18, 2024

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 42

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 3, 2025	Amendment	$452,000,000	No comparison	42	SEC filing
Jun 17, 2024	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-516125

Source: Form D, filed Oct 3, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND V-A, L.P.

Investment adviser: DECHENG CAPITAL LLC

Gross asset value: $32.9M
Beneficial owners: 2
ADV minimum commitment: $5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C FUND SERVICES (ASIA) LIMITED HONG KONG, Hong Kong Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor PRICEWATERHOUSECOOPERS LLP SAN FRANCISCO, California, United States

Custodian FIRST-CITIZENS BANK & TRUST COMPANY SANTA CLARA, California, United States Related to adviser: No

Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

PRICEWATERHOUSECOOPERS LLP
PCAOB 238

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

Filing source

Form ADV 2071333 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-9224339589

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Decheng Capital Global Life Sciences Fund IV, L.P.	Dec 15, 2020	Yet to sell	0
Decheng Capital Global Life Sciences Fund V, L.P. (this fund)	Oct 3, 2025	$452,000,000	42

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Xiangmin Cui	Director
N/A N/A Decheng Capital Management V (Cayman), Llc	Promoter
Yuheng Qiu	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Maples Corporate Services Limited Ugland House, P.O. Box 309
Grand Cayman, E9, KY1-1104